secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2026-05-21T20:30:16+00:00
Accession:  0001193125-26-234571
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro shareholders approve 1M share increase in 2013 incentive plan; board committees reappointed
--------------------------------------------------------------------------------

- Shareholders approved 7th Amended 2013 Incentive Compensation Plan, increasing share pool by 1,000,000 shares to 7,806,250 total.
- All seven director nominees elected with >96% votes for each: Burnett, Fallon, Fletcher, Johnson, Klein, Liau, Richards.
- Ratification of Cherry Bekaert LLP as auditor: 19.3M for, 20K against; advisory executive compensation approved 8.8M for, 442K against.
- Board committees reappointed: Audit (Fallon chair), Compensation (Johnson chair), Governance (Fletcher chair); Fletcher confirmed as Chairman.
- Non-employee director annual award cap set at 60,000 shares per year under the amended plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000119312526234571/0001193125-26-234571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000119312526234571/clpt-20260520.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-234571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer